Copy
New and Notable Evidence 2021
View this email in your browser
Trusted evidence. Informed decisions. Better health.

New and Notable Evidence | April 2021

Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!

Content:

Abortion 

Trials
Ali MK, Emam SM, Abdel-Aleem MA, Sobh AMA. Misoprostol versus expectant management in women with incomplete first-trimester miscarriage after failed primary misoprostol treatment: A randomized clinical trial. Int J Gynaecol Obstet. 2021 Feb 22. 
DOI: 10.1002/ijgo.13652. PMID: 33615468

Hamel C, Coppus S, van den Berg J, Hink E, van Seeters J, van Kesteren P, Merién A, Torrenga B, van de Laar R, Terwisscha van Scheltinga J, Gaugler-Senden I, Graziosi P, van Rumste M, Nelissen E, Vandenbussche F, Snijders M. Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial. EClinicalMedicine. 2021 Jan 6;32:100716. 
DOI: 10.1016/j.eclinm.2020.100716. PMID: 33681738.
FREE FULL TEXT


Reviews
Kristiansen MB, Shayo BC, Philemon R, Khan KS, Rasch V, Linde DS. Medical management of induced and incomplete first-trimester abortion by non-physicians in low- and middle-income countries: A systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand. 2021 Mar 16. 
DOI: 10.1111/aogs.14134. PMID: 33724458 

Zhuo Y, Cainuo S, Chen Y, Sun B. The efficacy of letrozole supplementation for medical abortion: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2021 May;34(9):1501-1507. 
DOI: 10.1080/14767058.2019.1638899. PMID: 31257957

Contraception 

Trials
Chin-Quee DS, Abrejo F, Chen M, Lashari T, Olsen P, Habib Z, Gao X, Assad F, Midhet F, Chandio S, Stankevitz K, Saleem S. Task Sharing of Injectable Contraception Services in Pakistan: A Randomized Controlled Trial. Stud Fam Plann. 2021 Mar;52(1):23-39. 
DOI: 10.1111/sifp.12149. PMID: 33742478

Daykan Y, Battino S, Arbib N, Tamir Yaniv R, Schonman R, Klein Z, Pomeranz J, Pomeranz M. Verbal analgesia is as good as oral tramadol prior to intrauterine device (IUD) insertion, among nulliparous women: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:443-446. 
DOI: 10.1016/j.ejogrb.2020.09.019. PMID: 33187752

de Jesus Antunes N, de Oliveira Filho RV, de Oliveira Ilha J, Moreno RA, Nahoum AF, Wedemeyer RS, Warnke A, De Nucci G. Single-dose pharmacokinetics and pharmacodynamics assessment of oestriol and trimegestone containing vaginal rings in healthy women with childbearing potential. Eur J Contracept Reprod Health Care. 2021 Mar 1:1-17. 
DOI: 10.1080/13625187.2021.1884219. PMID: 33645377

Duijkers I, Klipping C, Kinet V, Jost M, Bastidas A, Foidart JM. Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function. Contraception. 2021 Mar 6:S0010-7824(21)00058-5. 
DOI: 10.1016/j.contraception.2021.03.003. PMID: 33689786 
FREE FULL TEXT

Tebb KP, Rodriguez F, Pollack LM, Adams S, Rico R, Renteria R, Trieu SL, Hwang L, Brindis CD, Ozer E, Puffer M. Improving Contraceptive Use Among Latina Adolescents: A Cluster-Randomized Controlled Trial Evaluating an mHealth Application, Health-E You/Salud iTu. Contraception. 2021 Mar 17:S0010-7824(21)00059-7. 
DOI: 10.1016/j.contraception.2021.03.004. PMID: 33744300 
FREE FULL TEXT

Umlauff L, Weil P, Zimmer P, Hackney AC, Bloch W, Schumann M. Oral Contraceptives Do Not Affect Physiological Responses to Strength Exercise. J Strength Cond Res. 2021 Apr 1;35(4):894-901. 
DOI: 10.1519/JSC.0000000000003958. PMID: 33555830


Reviews
Abu-Zaid A, Alshahrani MS, Albezrah NA, Miski NT, Abuzaid M, Aboudi SA, Baredwan A, Almadhi N, Baradwan A, Alomar O, Salem H, A Al-Badawi I, Baradwan S. Vaginal dinoprostone versus placebo for pain relief during intrauterine device insertion: a systematic review and meta-analysis of randomised controlled trials. Eur J Contracept Reprod Health Care. 2021 Mar 11:1-13. 
DOI: 10.1080/13625187.2021.1891411. PMID: 33691549

Twirla - a new contraceptive patch. Med Lett Drugs Ther. 2021 Feb 8;63(1617):17-18.
PMID: 33647003  

Stokholm Baekgaard R, Gjaerevold Damhaugh E, Mrema D, Rasch V, Khan K, Linde DS. Training of healthcare providers and use of long-acting reversible contraception in low- and middle-income countries: A systematic review. Acta Obstet Gynecol Scand. 2021 Feb 16. 
DOI: 10.1111/aogs.14127. PMID: 33594675


Protocols - Cochrane Fertility Regulation Review Group
Interventions for vaginal bleeding irregularities with contraceptive implant
Ying Hu Kunyan Zhou Dan Shan Meina Yang
Version published: 16 March 2021
DOI: 10.1002/14651858.CD014649


Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
Megan A Cohen Fiona Stewart Robin Paynter Alison Edelman Jillian Henderson
Version published: 25 March 2021
DOI: 10.1002/14651858.CD014908

Family Planning 

Trials
Jones HE, Martin CE, Andringa KR, Ellerson RM, Johnson E, Hairston E, O' Grady KE. Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder. Drug Alcohol Depend. 2021 Apr 1;221:108634. 
DOI: 10.1016/j.drugalcdep.2021.108634. PMID: 33676071


Reviews
Craig LE, Chen ZE, Barrie J. Disability, sexual and reproductive health: a scoping review of healthcare professionals' views on their confidence and competence in care provision. BMJ Sex Reprod Health. 2021 Mar 18:bmjsrh-2020-200967. 
DOI: 10.1136/bmjsrh-2020-200967. PMID: 33737315 

Nabulsi D, Abou Saad M, Ismail H, Doumit MAA, El-Jamil F, Kobeissi L, Fouad FM. Minimum initial service package (MISP) for sexual and reproductive health for women in a displacement setting: a narrative review on the Syrian refugee crisis in Lebanon. Reprod Health. 2021 Mar 8;18(1):58. 
DOI: 10.1186/s12978-021-01108-9. PMID: 33685476  
FREE FULL TEXT
Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!


New & Notable Evidence is a free monthly email service of the
Cochrane Fertility Regulation Review Group

 
Keep up to date and subscribe here!
Website
Website
Twitter
Twitter
Email
Email
Copyright © 2021 Cochrane Fertility Regulation Group, All rights reserved.


unsubscribe from this list    update subscription preferences 

Please note: unsubscribing will remove you from the Cochrane Fertility Regulation Group's mailing list, but it will not automatically unsubscribe you from other Cochrane Groups' mailing lists or from Cochrane’s organizational mailing lists which you can manage at account.cochrane.org.

Email Marketing Powered by Mailchimp